C10022697 / invoice 10000
Species:CANINE
Breed:English Mastiff
Age (years):11
Diagnosis or signs:see history attached
Consult notes
12/03/2026 Diagnosis:: Diffuse large cell lymphoma (histological diagnosis), Stage IIIA. IHC B -Cell. Vincristine week 14. History: Alice has been very well. Her appetite, thirst, toileting and energy levels remain normal. There are no new concerns with Alice. Physical Examination findings: Bright, alert and responsive. Mm pink, crt < 2 secs, HR124, RR 20, Temp 38.1, Wt: 41.9kg Cardiovascular: muffled heart sound - likely anatomical Respiratory: normal respiratory rate and effort, normal bronchovesicular sounds on auscultation, no visible nasal discharge Gastrointestinal: soft comfortable abdomen on palpation, no strong repeatable focus of pain, Rectal exam: not performed Musculoskeletal: right tarsus markedly thickened and warm to the touch, there is no pain on manipulation or palpation Neurological: cranial nerves intact, no notable ataxia Integument: no obvious lesions Lymph Nodes: right popliteal enlarged. soft to firm Laboratory results: CBC performed in house with manual blood film assessment. Hct: 0.379 WCC: 3.38 Neuts:2.73 Platelets: 361 Manual differential count: Neutrophils 60%, Lymphocytes 30%, Monocytes 8%, Eosinophils 1%. Platelets: clumped and adequate Morphology: Normal Treatment:36.5mg doxorubicin (30mg/m2) was administered slow IV, in a saline infusion, via a 22g catheter in the right medial saphenous vein using the closed injection Equashield system. Cerenia as required Comments: We will see Alice again in 2 weeks time. Please feel free to call or email if you have any further queries regarding Alice.
Previous claim history (8)
| Date | Claim # | Diagnosis |
|---|---|---|
| 2026-02-09 | C09888534 | SEPTIC ARTHRITIS |
| 2026-02-07 | C09875846 | LYMPHOMA (MALIGNANT) |
| 2026-02-05 | C09858123 | LYMPHOMA (MALIGNANT) |
| 2026-01-22 | C09796558 | LYMPHOMA (MALIGNANT) |
| 2026-01-15 | C09763337 | LYMPHOMA (MALIGNANT) |
| 2026-01-02 | C09700703 | LYMPHOMA (MALIGNANT) |
| 2025-12-18 | C09646818 | LYMPHOMA (MALIGNANT) |
| 2025-12-11 | C09612836 | LYMPHOMA (MALIGNANT) |
Line items(lines with upstream diagnosis are skipped by the model)
| Line | tstarc | Amount | Date | Upstream diagnosis |
|---|---|---|---|---|
| 10000 | tstarc_chemotherapy_-_doxorubicin | 485.00 | 2026-03-12 | — |
| 20000 | tstarc_consultation-revisit | 205.00 | 2026-03-12 | — |
| 30000 | tstarc_diagnostic_test_-_haematology | 126.50 | 2026-03-12 | — |
| 40000 | tstarc_chemotherapy | 375.00 | 2026-03-12 | — |
UPM+
- DG02636LYMPHOMA (MALIGNANT)DSTP_lymphoma
Variant (sleepy_king)
LYMPHOMA (MALIGNANT)
DSTP_lymphoma
Conf: 0.990
Threshold: 0.19
Above: ✓
Correct?